Literature DB >> 22948717

Yes is a central mediator of cell growth in malignant mesothelioma cells.

Ayami Sato1, Miki Sekine, Nantiga Virgona, Masako Ota, Tomohiro Yano.   

Abstract

The constitutive activation of the Src family kinases (SFKs) has been established as a poor prognostic factor in malignant mesothelioma (MM), however, the family member(s) which contribute to the malignancy have not been defined. This study aimed to identify the SFK member(s) contributing to cell growth using RNA interference in various MM cell lines. Silencing of Yes but not of c-Src or Fyn in MM cells leads to cell growth suppression. This suppressive effect caused by Yes silencing mainly depends on G1 cell cycle arrest and partly the induction of apoptosis. Also, the knockout of Yes induces the inactivation of β-catenin signaling and subsequently decreases the levels of cyclin D necessary for G1-S transition in the cell cycle. In addition, Yes knockout has less effect on cell growth suppression in β-catenin-deficient H28 MM cells compared to other MM cells which express the catenin. Overall, we conclude that Yes is a central mediator for MM cell growth that is not shared with other SFKs such as c-Src.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22948717     DOI: 10.3892/or.2012.2010

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  11 in total

1.  The Src family tyrosine kinases src and yes have differential effects on inflammation-induced apoptosis in human pulmonary microvascular endothelial cells.

Authors:  Leif D Nelin; Hilary A White; Yi Jin; Jennifer K Trittmann; Bernadette Chen; Yusen Liu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-02-26       Impact factor: 5.464

2.  Gene expression of mesothelioma in vinylidene chloride-exposed F344/N rats reveal immune dysfunction, tissue damage, and inflammation pathways.

Authors:  Pamela E Blackshear; Arun R Pandiri; Hiroaki Nagai; Sachin Bhusari; Hue-Hua Hong; Thai-Vu T Ton; Natasha P Clayton; Michael Wyde; Keith R Shockley; Shyamal D Peddada; Kevin E Gerrish; Robert C Sills; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2014-06-23       Impact factor: 1.902

3.  Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Platelet-derived Growth Factor Receptor α and Yes Kinase.

Authors:  Yuki Ohkawa; Hiroyuki Momota; Akira Kato; Noboru Hashimoto; Yusuke Tsuda; Norihiro Kotani; Koichi Honke; Akio Suzumura; Keiko Furukawa; Yuhsuke Ohmi; Atsushi Natsume; Toshihiko Wakabayashi; Koichi Furukawa
Journal:  J Biol Chem       Date:  2015-05-04       Impact factor: 5.157

4.  Spontaneous mesotheliomas in F344/N rats are characterized by dysregulation of cellular growth and immune function pathways.

Authors:  Pamela E Blackshear; Arun R Pandiri; Thai-Vu T Ton; Natasha P Clayton; Keith R Shockley; Shyamal D Peddada; Kevin E Gerrish; Robert C Sills; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2013-08-26       Impact factor: 1.902

5.  Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1.

Authors:  Weiqi Tan; Seng-Gee Lim; Theresa M C Tan
Journal:  World J Gastroenterol       Date:  2015-12-14       Impact factor: 5.742

6.  Cyclin-dependent kinase 1-mediated phosphorylation of YES links mitotic arrest and apoptosis during antitubulin chemotherapy.

Authors:  Zhan Wang; Xingcheng Chen; Mei-Zuo Zhong; Shuping Yang; Jiuli Zhou; David L Klinkebiel; Adam R Karpf; Yuanhong Chen; Jixin Dong
Journal:  Cell Signal       Date:  2018-09-15       Impact factor: 4.315

7.  Identification of potent Yes1 kinase inhibitors using a library screening approach.

Authors:  Paresma R Patel; Hongmao Sun; Samuel Q Li; Min Shen; Javed Khan; Craig J Thomas; Mindy I Davis
Journal:  Bioorg Med Chem Lett       Date:  2013-05-29       Impact factor: 2.823

8.  miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1.

Authors:  Zheng Fang; Shuai Yin; Ruochuan Sun; Shangxin Zhang; Min Fu; Youliang Wu; Tao Zhang; Junaid Khaliq; Yongxiang Li
Journal:  Mol Cancer       Date:  2017-08-17       Impact factor: 27.401

9.  Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines.

Authors:  Valentina Monica; Marco Lo Iacono; Enrico Bracco; Simone Busso; Laura Di Blasio; Luca Primo; Barbara Peracino; Mauro Papotti; Giorgio Scagliotti
Journal:  Oncotarget       Date:  2016-11-22

10.  Etv2 transcriptionally regulates Yes1 and promotes cell proliferation during embryogenesis.

Authors:  Bhairab N Singh; Wuming Gong; Satyabrata Das; Joshua W M Theisen; Javier E Sierra-Pagan; Demetris Yannopoulos; Erik Skie; Pruthvi Shah; Mary G Garry; Daniel J Garry
Journal:  Sci Rep       Date:  2019-07-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.